Biotech Pharma dares an IPO

 In the time, when IPOs (Initial Public Offering) are facing huge financial issues while they debut on the world markets there are some daring to do so and as they say, risk-takers are money makers might just come through for these daring IPOs. The German developer of individualized treatments for cancer and other diseases Biotech today launched its initial public offering, raising about half of the maximum amount it projected late last m....